Harmony Biosciences Holdings, Inc.

NasdaqGM:HRMY 株式レポート

時価総額:US$1.9b

Harmony Biosciences Holdings 過去の業績

過去 基準チェック /36

Harmony Biosciences Holdingsは、平均年間66.5%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間1.2% 41.2%収益成長率で 成長しています。 Harmony Biosciences Holdingsの自己資本利益率は20.5%であり、純利益率は18%です。

主要情報

66.5%

収益成長率

87.4%

EPS成長率

Pharmaceuticals 業界の成長6.0%
収益成長率41.2%
株主資本利益率20.5%
ネット・マージン18.0%
前回の決算情報30 Sep 2024

最近の業績更新

Recent updates

Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points

Nov 11

Harmony Biosciences Holdings, Inc. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next

Oct 31
Harmony Biosciences Holdings, Inc. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next

Is Harmony Biosciences Holdings (NASDAQ:HRMY) Using Too Much Debt?

Oct 30
Is Harmony Biosciences Holdings (NASDAQ:HRMY) Using Too Much Debt?

Many Still Looking Away From Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Sep 25
Many Still Looking Away From Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Harmony Biosciences: Advancing An Expanded Pipeline

Aug 15

Harmony Biosciences Holdings (NASDAQ:HRMY) Has A Rock Solid Balance Sheet

Jul 15
Harmony Biosciences Holdings (NASDAQ:HRMY) Has A Rock Solid Balance Sheet

Investors Holding Back On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Jun 07
Investors Holding Back On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Harmony Biosciences Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 03
Harmony Biosciences Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely

Apr 04
These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely

Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings

Feb 09
Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings

Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Mar 21
Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?

Dec 01
Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?

Harmony Biosciences: In Harmony

Sep 23

We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease

Aug 05
We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease

Harmony Biosciences Non-GAAP EPS of $0.57 misses by $0.06, revenue of $107M beats by $6.25M

Aug 02

Harmony Biosciences: Steady Revenue Generator Looking For A Future

May 26

収支内訳

Harmony Biosciences Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqGM:HRMY 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Sep 24682123220141
30 Jun 24656115209134
31 Mar 2461813820185
31 Dec 2358212919376
30 Sep 2354215118256
30 Jun 2349920017779
31 Mar 2347218917277
31 Dec 2243818116371
30 Sep 2240115615768
30 Jun 223645814839
31 Mar 223314913733
31 Dec 213053513230
30 Sep 212711212631
30 Jun 212351711523
31 Mar 21200-710321
31 Dec 20160-649619
30 Sep 20109-1109219
30 Jun 2064-1469419
31 Mar 2026-1659020
31 Dec 196-1878170

質の高い収益: HRMYは 高品質の収益 を持っています。

利益率の向上: HRMYの現在の純利益率 (18%)は、昨年(27.8%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: HRMY過去 5 年間で収益を上げており、収益は年間66.5%増加しています。

成長の加速: HRMYは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: HRMYは過去 1 年間で収益成長率がマイナス ( -18.7% ) となったため、 Pharmaceuticals業界平均 ( 54.6% ) と比較することが困難です。


株主資本利益率

高いROE: HRMYの 自己資本利益率 ( 20.5% ) は 高い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘